Prohibits using cadaveric fetal tissue obtained from elective abortion procedure for research purposes and using any cadaveric fetal tissue to research cosmetic treatments.
Impact
The bill would have significant implications on state laws surrounding the ethical use of human tissues in research. By prohibiting the use of cadaveric fetal tissues obtained through elective abortions, A2076 reinforces existing protections against the commodification of fetal tissue. It ensures that patients undergoing infertility treatments are better informed about their choices regarding the disposition of embryos and fetal tissues, though it presents challenges for researchers reliant on such materials for scientific advancements.
Summary
Assembly Bill A2076 seeks to amend existing New Jersey laws regarding the use of cadaveric fetal tissue, specifically prohibiting its use in research derived from elective abortion procedures. This bill aims to restrict the application of such tissues for any research purposes, which aligns with the state's restrictive stance on the ethical implications of utilizing cadaveric fetal tissues. Additionally, the bill bans the use of cadaveric fetal tissue for research related to cosmetic treatments, underscoring a growing concern about the ethical dimensions of cosmetic applications using fetal tissue.
Contention
Notably, the legislation has sparked debate regarding the balance between scientific progress and ethical considerations. Supporters argue that the bill is essential for maintaining ethical standards in medical research, whereas opponents may contend that this restriction limits valuable research opportunities that could potentially lead to medical breakthroughs. Furthermore, the legislative discussions highlight broader societal tensions regarding reproductive rights and research ethics, reflecting ongoing controversies that surround the use of fetal tissues in academic and medical contexts.
Same As
Prohibits using cadaveric fetal tissue obtained from elective abortion procedure for research purposes and using any cadaveric fetal tissue to research cosmetic treatments.
Prohibits using cadaveric fetal tissue obtained from elective abortion procedure for research purposes and using any cadaveric fetal tissue to research cosmetic treatments.
Prohibits using cadaveric fetal tissue obtained from elective abortion procedure for research purposes and using any cadaveric fetal tissue to research cosmetic treatments.
Relating to prohibited state contracts with vendors that perform elective abortions, destructive embryonic stem cell research, or human cloning or that conduct research on human fetal tissue.
Relating to prohibited state contracts with vendors that perform elective abortions, destructive embryonic stem cell research, or human cloning or that conduct research on human fetal tissue.
Establishes criminal penalties for physicians who fail to provide certain information prior to performing abortion procedure involving donation of cadaveric fetal tissue.
Protecting Life and Integrity in Research Act of 2023 This bill restricts research that uses human fetal tissue from an induced abortion. Specifically, it prohibits the Department of Health and Human Services from conducting or supporting such research. Additionally, the bill applies requirements on the research of transplantation of fetal tissue for therapeutic purposes to research on fetal tissue in general. The bill also prohibits soliciting or acquiring a donation of human fetal tissue from an induced abortion, other than for purposes of an autopsy or burial.
Relating to certain prohibited abortions and the treatment and disposition of a human fetus, human fetal tissue, and embryonic and fetal tissue remains; creating a civil cause of action; imposing a civil penalty; creating criminal offenses.
Relating to certain prohibited abortions and the treatment and disposition of a human fetus, human fetal tissue, and embryonic and fetal tissue remains; creating a civil cause of action; imposing a civil penalty; creating criminal offenses.
Prohibits using cadaveric fetal tissue obtained from elective abortion procedure for research purposes and using any cadaveric fetal tissue to research cosmetic treatments.
Establishing certain notification and reporting requirements concerning pilot programs that research transcranial magnetic stimulation or electromagnetic brain pulse treatment. (BDR S-865)